The role of new technologies in the clinical assessment of gait in multiple sclerosis


Key to the clinical evaluation of the patient with multiple sclerosis (MS) is the gait assessment. Even subtle changes in walking can indicate ongoing disease activity and progression, and outcome measures of clinical trials for disease-modifying therapies often include gait. Due to the potential benefit for early intervention, gait impairments need to be detected at the earliest point of onset.

This brief review highlights clinical approaches for gait assessment in MS, with a focus on the emerging role of the technologies developed for human movement analysis. Wearable technologies in particular can address the important need for remote and at-home gait monitoring for use in teleneurology.